Nachrichten zur Liquidia Technologies Inc. Aktie

Liquidia Technologies hat nach der frühen Zulassung ihres Medikaments Yutrepia durch die FDA am 23. Mai 2025 mit einer schnellen…

Liquidia Technologies stock hits 52-week high at 19.46 USD…

Liquidia Technologies (LQDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

Liquidia Technologies stock surges on legal win…

Liquidia Technologies (LQDA) delivered earnings and revenue surprises of -21.05% and 43.11%, respectively, for the quarter ended December 2024. Do…

The consensus price target hints at a 126.1% upside potential for Liquidia Technologies (LQDA). While empirical research shows that this…

Liquidia Technologies (LQDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims…

NEW YORK, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims…

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -82.61% and 14.35%, respectively, for the quarter ended December 2023.…